Akeso

This study tested whether combining two experimental immunotherapy drugs (AK112 and AK117) with or without chemotherapy could help control advanced cancers. The trial enrolled 154 adults with various advanced solid tumors including stomach, bile duct, pancreatic, and lung cancers…

This study tested a new drug called AK112 in patients with advanced liver cancer that could not be surgically removed. AK112 is designed to target two pathways involved in cancer growth at once. The main goals were to see if the drug was safe and if it could shrink tumors or stop…

This large Phase 3 trial tested whether adding a new immune-boosting drug called AK104 to standard chemotherapy works better than chemotherapy alone for people with advanced stomach or gastroesophageal cancer. The study involved 610 adults who had not received prior treatment for…

This study tested whether an investigational drug called AK111 could reduce symptoms and improve quality of life for people with active ankylosing spondylitis, a painful inflammatory arthritis of the spine. Over 500 participants were randomly assigned to receive either AK111 or a…

This study tested an investigational drug called AK120 in adults with moderate to severe atopic dermatitis (eczema). The main goal was to see if the drug safely reduces the severity and extent of the skin rash. About 450 participants received the treatment and were followed for a…

This study tested an experimental drug called AK112 in 108 people with advanced non-small cell lung cancer. AK112 is a single antibody designed to attack cancer in two ways at once: by blocking a protein that helps tumors hide from the immune system and by cutting off their blood…